Table 1.
Baseline characteristics of the study patients.
| Labetalol (n = 32) | Lidocaine (n = 32) | |
|---|---|---|
| Age (year) | 37.06 ± 9.05 | 41.83 ± 11.24 |
| Sex, Male (n, %) | 13 (40) | 9 (28) |
| Body weight (Kg) | 64.7 ± 11.1 | 65.1 ± 8.3 |
| ASA (I/II) | 25/7 | 27/5 |
| SBP (mmHg) | 125.5 (118.25–138.5) | 125 (118.5–136) |
| DBP (mmHg) | 85 (77.5–88.25) | 84 (79–91) |
| MAP (mmHg) | 99.5 (94.25–108.25) | 96.5 (91.25–110) |
| HR (beats/min) | 88.5 (77.5–97) | 82.5 (73.25–92.75) |
| SpO2 (%) | 98 (97–100) | 99 (98–100) |
| ETCO2 (mmHg) | 32 (30–36.5) | 30 (28–33.5) |
The values indicate mean ± SD or median (Q1‒Q3) or number of patients (percentage).